Pfizer Inc. has recalled 103,150 vials of Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) after a complaint was received regarding the presence of a hair in one vial. This prescription medication is used to treat respiratory conditions and was distributed by Hospira, Inc. throughout the United States and Puerto Rico. While one complaint has been received, no injuries or illnesses have been reported to date in connection with this issue.
The presence of particulate matter like hair in a sterile injectable drug can cause inflammation, allergic reactions, or blood vessel blockages. If a particle travels through the bloodstream to vital organs, it could lead to serious medical complications.
Distributed by Hospira, Inc. Lake Forest, IL 60045 USA. Single-dose vial, Rx only.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.